Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Gross Profit (2018 - 2025)

Health Catalyst (HCAT) has disclosed Gross Profit for 8 consecutive years, with $38.2 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Gross Profit rose 6.69% year-over-year to $38.2 million, compared with a TTM value of $175.3 million through Jun 2025, up 57.63%, and an annual FY2023 reading of $131.8 million, down 1.02% over the prior year.
  • Gross Profit was $38.2 million for Q2 2025 at Health Catalyst, up from $36.2 million in the prior quarter.
  • Across five years, Gross Profit topped out at $65.0 million in Q3 2024 and bottomed at -$39.0 million in Q4 2023.
  • Average Gross Profit over 5 years is $34.6 million, with a median of $36.2 million recorded in 2025.
  • The sharpest move saw Gross Profit surged 376.15% in 2022, then plummeted 317.98% in 2023.
  • Year by year, Gross Profit stood at -$6.5 million in 2021, then soared by 376.15% to $17.9 million in 2022, then tumbled by 317.98% to -$39.0 million in 2023, then soared by 266.82% to $65.0 million in 2024, then tumbled by 41.18% to $38.2 million in 2025.
  • Business Quant data shows Gross Profit for HCAT at $38.2 million in Q2 2025, $36.2 million in Q1 2025, and $65.0 million in Q3 2024.